View Older Stories View More Recent Stories

Apr 17, 2025 10:25AM Eli Lilly & Co. (LLY) call put ratio 1.4 calls to 1 put as share price up 13%

Apr 17, 2025 09:19AM Leerink Partners Reiterates Outperform Rating on Eli Lilly (LLY)

Apr 17, 2025 07:33AM Eli Lilly shares jump 12% on positive Phase 3 results for oral diabetes drug

Apr 17, 2025 06:54AM Eli Lilly & Co. (LLY) Shares Up 13% on GLP-1 Study Update, Trading 832 Handle

Apr 17, 2025 06:50AM Eli Lilly & Co. (LLY) oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial

Apr 15, 2025 10:49AM Bernstein: 'Eli Lilly (LLY) Keeps Taking Share'

Apr 9, 2025 09:19AM Pharma stocks slide after Trump signals tariffs on sector

Apr 8, 2025 05:08AM Goldman Sachs Upgrades Eli Lilly (LLY) to Buy

Apr 7, 2025 06:38AM BofA: 'Weekly GLP-1 TRx growth in March is trending slightly ahead of February'

Apr 4, 2025 04:23PM Trump Admin Drops Biden Medicare Obesity Drug Coverage Proposal - Bloomberg

Apr 1, 2025 04:00PM BofA highlights 10 stocks to own for Q2

Apr 1, 2025 01:31PM Hims & Hers Health (HIMS) expanding access to personalized weight loss care

Apr 1, 2025 01:04PM Hims & Hers Health, Inc. (HIMS) said to sell Lilly's Zepbound

Apr 1, 2025 09:33AM Bernstein Assesses U.S. Biopharma Stocks Amid Tariff Risks

Apr 1, 2025 06:17AM Wells Fargo Releases Regular Quarterly Update to Tactical Ideas List

Mar 31, 2025 04:57AM Stocks expected to have increasing option volume: LLY NVO TEM SPY QQQ

Mar 28, 2025 07:19AM Lilly's (LLY) Kisunla Fails To Get Eu Approval In Early Alzheimer's

Mar 28, 2025 06:40AM Eli Lilly & Co. (LLY) call put ratio 1 call to 1.3 puts

Mar 27, 2025 08:06AM Organovo (ONVO) Provides Business Update

Mar 26, 2025 06:00PM Weighing in on obesity: Catalyst-rich 2025 ahead in a growing competitive landscape

Mar 26, 2025 09:45AM Truist Weighs In on Obesity: 'Catalyst-Rich 2025 Ahead in a Growing Competitive Landscape'

Mar 25, 2025 11:28AM Organovo (ONVO) Announces Close of the Sale of FXR Program to Eli Lilly and Company (LLY)

Mar 25, 2025 10:12AM Bernstein on Eli Lilly (LLY): 'We Like the Lead that Retatrutide Has'

Mar 24, 2025 12:54PM Investment commitments in U.S. nears $3 trillion since Trump took office

Mar 24, 2025 10:17AM Jefferies Reiterates Buy Rating on Eli Lilly (LLY)

Mar 24, 2025 09:00AM UBS Reiterates Buy Rating on Eli Lilly (LLY)

Mar 18, 2025 07:57AM Bernstein on Eli Lilly (LLY): 'LLY Takes Majority Share & Anti-Cancer Potential for Retatrutide'

Mar 18, 2025 06:52AM Cantor Fitzgerald says more options, newer targets will expand obesity market

Mar 16, 2025 10:00AM Will Pfizer step into the obesity ring? Wolfe Research answers

Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma

Mar 15, 2025 04:00AM How could tariffs shake up the pharma sector?

Mar 10, 2025 08:02AM Morgan Stanley Reiterates Overweight Rating on Eli Lilly (LLY)

Mar 7, 2025 08:32AM Eli Lilly's (LLY) EBGLYSS single monthly maintenance injection achieved completely clear skin at three years in half of patients with moderate-to-severe atopic dermatitis

Mar 6, 2025 08:52AM Teladoc (TDOC) +2% on addition of GLP-1 self-pay option with Lilly

Mar 6, 2025 07:59AM Bernstein Reiterates Market Perform on Novo Nordisk (NOVOB:DC) (NVO) Following NovoCare Pharmacy Launch

Mar 5, 2025 09:26AM Amgen (AMGN) Starts Late-stage Studies Of Monthly Obesity Drug - Bloomberg, Citing Comments at Conf.

Mar 5, 2025 07:44AM Bernstein on Eli Lilly (LLY): '2025 is a Catalyst-Rich Year for LLY'

Mar 4, 2025 06:49AM Bernstein: 'Eli Lilly (LLY) Continues to Outgrow Novo'

Feb 28, 2025 08:15AM Lilly's (LLY) Jaypirca recommended by CHMP for approval in EU for adults with r/r CLL

Feb 28, 2025 07:48AM Bernstein on Eli Lilly (LLY) Amid US Biopharma Policy: 'LLY Leans In'

Feb 26, 2025 02:01PM Eli Lilly to invest another $27 billion in U.S. manufacturing

Feb 26, 2025 12:19PM Deutsche Bank Reiterates Buy Rating on Eli Lilly (LLY) Amid New U.S. Investment

Feb 26, 2025 10:00AM JPMorgan Reiterates Overweight Rating on Eli Lilly (LLY)

Feb 26, 2025 09:30AM Eli Lilly & Co. (LLY) to more than double U.S. manufacturing investment since 2020 exceeding $50B

Feb 26, 2025 09:23AM BMO Capital Reiterates Outperform on Eli Lilly (LLY) After Self Pay Program Expansion

Feb 26, 2025 06:39AM Eli Lilly (LLY) Lowers Zepbound Price; Bernstein: 'This is Something We'd Been Hoping to See'

Feb 25, 2025 08:06AM Organovo's (ONVO) FXR Program, including FXR314, Acquired by Eli Lilly (LLY)

Feb 25, 2025 06:46AM Eli Lilly & Co. (LLY) launches additional Zepbound vial doses and offers new savings for self-pay patients

Feb 24, 2025 07:19AM Bernstein Sees 'Clear Upside' for Eli Lilly's (LLY) Zepbound and Mounjaro Post FDA Announcement

Feb 22, 2025 04:00AM What's the current state of China's GLP-1 market?

View More Recent Stories View Older Stories